Ophthalmology
Ocumetics Reports Life-Changing Six-Month Results from First-in-Human Study of Accommodating Intraocular Lens
Ocumetics Technology Corp. announced that six-month postoperative results from its first-in-human study of the Ocumetics Accommodating Intraocular Lens show continued vision improvements and meaningful quality-of-life enhancements for patients, with plans to advance to Group Two surgeries.
Ocumetics Reports Promising Early Results in First Human Lens Implant Study
Ocumetics Technology Corp. announced encouraging one-month vision results from its first human clinical study of an accommodating intraocular lens, showing potential to transform cataract treatment and reduce dependence on corrective lenses.
AXIM Biotechnologies Secures Exclusive South Korean Distribution for TearScan Diagnostic Tests
AXIM Biotechnologies has partnered with VisionPlus Corp. to exclusively distribute its TearScan diagnostic tests in South Korea, expanding access to advanced ocular diagnostics in a market experiencing rising dry eye disease cases.
EHNOTE to Unveil Integrated Ophthalmology Platform at AAO 2025
EHNOTE's upcoming showcase at the American Academy of Ophthalmology 2025 conference introduces a unified cloud platform that could significantly reduce administrative burden and improve workflow efficiency for eye care practices.
Ocumetics Reports Promising Early Results for Vision-Restoring Lens Technology
Ocumetics Technology Corp. has reported encouraging one-month postoperative results for its accommodating intraocular lens, showing potential to restore natural vision across distances without glasses.
AXIM Biotechnologies Partners with JK Medical to Expand Ocular Diagnostic Access Across Latin America
AXIM Biotechnologies has entered an exclusive licensing agreement with JK Medical to distribute its TearScan® diagnostic tests across seven Latin American countries, addressing critical unmet needs in dry eye disease diagnosis through rapid point-of-care testing.
Ocumetics Completes One-Month Postoperative Examinations for Revolutionary Intraocular Lens
Ocumetics Technology Corp. has completed critical one-month postoperative examinations for its innovative accommodating intraocular lens, marking a significant milestone in developing a potential vision correction solution that could eliminate the need for glasses or contact lenses.
ABVC BioPharma Achieves $100,000 Licensing Milestone with ForSeeCon, Enhancing Ophthalmology Focus
ABVC BioPharma's recent $100,000 milestone payment from ForSeeCon Eye Corporation underscores the growing commercial interest in its ophthalmology solutions, particularly Vitargus®, and strengthens its position in the global eye care market.
Diopter Technologies Advances Ocular Disease Treatment with Dissolving Contact Lens
Diopter Technologies has completed early clinical studies for a dissolving amniotic membrane biopolymer contact lens, offering a novel approach to treating ocular surface diseases by delivering growth factors directly to the eye.
FELIQS Secures $9 Million in Series A Funding to Advance Treatment for Retinopathy of Prematurity
FELIQS Corporation's $9 million Series A funding will accelerate the clinical development of FLQ-101, a promising treatment for retinopathy of prematurity, addressing a critical unmet need in neonatal care.
Tenpoint Therapeutics Strengthens Leadership Team with Appointment of Melissa Epperly as CFO
Tenpoint Therapeutics appoints Melissa Epperly as CFO to lead financial strategy and operations, marking a pivotal step towards the potential U.S. launch of its innovative treatment for presbyopia, BRIMOCHOLPF.
Telomir Pharmaceuticals Reveals Promising Vision Restoration in Preclinical AMD Study
Telomir Pharmaceuticals has demonstrated its oral therapeutic candidate Telomir-1 can restore vision and reverse retinal degeneration in a zebrafish model of age-related macular degeneration, highlighting potential breakthrough treatment for vision loss.
Simple Eye Exam Could Enable Early Parkinson's Detection, Researchers Find
A new study from Universite Laval suggests that a straightforward retinal examination might provide an early diagnostic method for Parkinson's disease, potentially transforming how medical professionals identify and track the neurological condition.
EHNOTE Unveils Comprehensive Ophthalmology Software Platform at ASCRS-ASOA 2025
EHNOTE introduces a groundbreaking, fully integrated software platform designed exclusively for ophthalmology practices, promising to streamline clinical workflows, enhance patient care, and reduce administrative burden through a unified technological ecosystem.
EHNOTE Unveils Comprehensive Ophthalmology Software Platform at ASCRS 2025
EHNOTE introduces a groundbreaking, unified software ecosystem designed exclusively for ophthalmology practices, promising to streamline clinical workflows and enhance patient care through an integrated platform that addresses multiple operational needs.